title: Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.
authors.affiliation: Division of Hematology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
authors.forename: Erica A
authors.initials: EA
authors.lastname: Peterson
authors.forename: Leslie
authors.initials: L
authors.lastname: Zypchen
authors.forename: Vivian H Y
authors.initials: VH
authors.lastname: Lee
authors.forename: Janet
authors.initials: J
authors.lastname: Nitta
authors.forename: Lynda M
authors.initials: LM
authors.lastname: Foltz
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D001856:Bone Marrow Examination / Q000706:statistics & numerical data; D001955:British Columbia; D015331:Cohort Studies; D005260:Female; D019983:Guideline Adherence; D006785:Hospitals, University; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D009154:Mutation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012189:Retrospective Studies; D016019:Survival Analysis; D013920:Thrombocythemia, Essential / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D014944:World Health Organization
chemical_list: D010975:Platelet Aggregation Inhibitors; C507924:JAK2 protein, human; D053614:Janus Kinase 2